Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Sean E. Collins"'
Autor:
Lilai Jin, Sarah J. Higgins, James A. Thompson, Michael P. Strager, Sean E. Collins, Jason A. Hubbart
Publikováno v:
Water, Vol 16, Iss 5, p 735 (2024)
Saturated hydraulic conductivity (Ksat) is a hydrologic flux parameter commonly used to determine water movement through the saturated soil zone. Understanding the influences of land-use-specific Ksat on the model estimation error of water balance co
Externí odkaz:
https://doaj.org/article/0373554b52a74c07a4e92602f5ff720e
Autor:
Paul E. Sax, Kristen Andreatta, Jean-Michel Molina, Eric S. Daar, Debbie Hagins, Rima Acosta, Michelle L. D’Antoni, Silvia Chang, Ross Martin, Hui Liu, Christiana Blair, Ian McNicholl, Joel Gallant, Sean E. Collins, Hal Martin, Kirsten L. White
Publikováno v:
AIDS. 36:1511-1520
We investigated the prevalence of preexisting M184V/I and associated risk factors among clinical trial participants with suppressed HIV and evaluated the impact of M184V/I on virologic response after switching to bictegravir/emtricitabine/tenofovir a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6708a378d909f6a774c7479a369e97a4
https://doi.org/10.1097/qad.0000000000003244
https://doi.org/10.1097/qad.0000000000003244
Autor:
Dominique L Braun, Casper Rokx, Sean E Collins, Ross Martin, Nicolas A. Margot, Stephanie Cox, Brian Moldt, Hui Liu, Jiani Li, Susan J. Little, Romas Geleziunas, Tariro Makadzange, Clara Lehmann, Edgar T. Overton, Lisa Selzer, Kimberly A. Workowski, Christian Callebaut, Joseph J. Eron, Aiyappa Parvangada, Michael J. Kozal, Debbie Slamowitz, Rajesh T. Gandhi, Huldrych F. Günthard
Publikováno v:
AIDS, 36(2), 205-214. Lippincott Williams & Wilkins
Objective: Persistence of the viral reservoir is the main barrier to curing HIV. Initiation of ART during acute HIV infection can limit the size and diversity of the reservoir. In depth characterization of the reservoir in individuals who initiate AR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b181d0bb75524747c5f63551167781f8
https://doi.org/10.1097/qad.0000000000003088
https://doi.org/10.1097/qad.0000000000003088
Autor:
Eva Natukunda, Sean E Collins, Susan K. Chuck, Diana M. Brainard, Faiza Ajana, Hui Wang, Kirsten White, Chloe Orkin, Cheryl A. Pikora, Cissy Kityo, Tariro Makadzange, Ya-Pei Liu, Bhumi Gandhi-Patel, Xuelian Wei, Ian R. McNicholl, Ellen Koenig
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Background: We characterized the efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in a broad population of pediatric/adolescent/adult/elderly females living with HIV (FWH). Setting: Integrated analysis. Methods: Availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1c9770face3dd8231e537eb4f93f45
http://europepmc.org/articles/PMC8547745
http://europepmc.org/articles/PMC8547745
Autor:
Olayemi Osiyemi, Indira Brar, Moti Ramgopal, Diana M. Brainard, Anson K Wurapa, Princy Kumar, Daniel S Berger, Hal Martin, Kristen Andreatta, Braave Investigators, Michael S. Saag, Sean E Collins, Debbie Hagins, Corrilynn O. Hileman, Christiana Blair, Cheryl McDonald
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
Background: With the highest rates of HIV/AIDS in the United States, Black Americans are still underrepresented in HIV medical research. Setting: BRAAVE (NCT03631732) is a randomized, phase
Background: With the highest rates of HIV/AIDS in the United States, Black Americans are still underrepresented in HIV medical research. Setting: BRAAVE (NCT03631732) is a randomized, phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9935245046c472abc2efac81b2b9638
http://europepmc.org/articles/PMC8357046
http://europepmc.org/articles/PMC8357046
Autor:
Ross Martin, Sean E Collins, Madeleine Willkom, Hal Martin, Aiyappa Parvangada, Hui Liu, Kristen Andreatta, Kirsten L. White, Rima Acosta
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 85:363-371
BACKGROUND Study 4030 was a phase 3, randomized, double-blinded study of 565 HIV-1 RNA-suppressed participants switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) or dolutegravir (DTG)+F/TAF. Nucleoside reverse transcriptase inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a35075ce9fd7e65fb1825f9329a63cf7
https://doi.org/10.1097/qai.0000000000002454
https://doi.org/10.1097/qai.0000000000002454
Autor:
Joss J De Wet, Amanda Clarke, Karam Mounzer, Lijie Zhong, Moupali Das, Frank A. Post, Diana M. Brainard, Heiko Jessen, Edwin DeJesus, Sean E Collins, Anita Mathias, Pamela Wong, C. Bradley Hare, Pep Coll, Cynthia Brinson, Scott McCallister, Kenneth H. Mayer, Christian Callebaut, Peter Ruane, Robert M. Grant, Ramin Ebrahimi, Melanie A. Thompson, Jean-Michel Molina, Peter L. Anderson
Publikováno v:
The Lancet. 396:239-254
Summary Background Tenofovir alafenamide shows high antiviral efficacy and improved renal and bone safety compared with tenofovir disoproxil fumarate when used for HIV treatment. Here, we report primary results from a blinded phase 3 study evaluating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc8b9b2d5ce214f9b1cfbefa42d6dc3c
https://doi.org/10.1016/s0140-6736(20)31065-5
https://doi.org/10.1016/s0140-6736(20)31065-5
Autor:
David A. Wohl, Claudia Martorell, Amanda Clarke, Sean E Collins, Jason Flamm, Samir K. Gupta, Edwin DeJesus, Hans-Jürgen Stellbrink, Hal Martin, Daniel Podzamczer, Debbie Hagins, Jose R. Arribas, Diana M. Brainard, Franco Maggiolo, Cynthia Brinson, Gs-Us Investigators, Paul E. Sax, Rima Acosta, Gs-Us, Jeffrey L. Stephens, Melanie A. Thompson, Hailin Huang, Chloe Orkin
Publikováno v:
The Lancet HIV. 7:e389-e400
Summary Background In the primary week-48 analyses of two phase 3 studies, coformulated bictegravir, emtricitabine, and tenofovir alafenamide was non-inferior to a dolutegravir-containing regimen in treatment-naive people with HIV. We report week-144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad9159a592ef89389d02762f33066298
https://doi.org/10.1016/s2352-3018(20)30099-0
https://doi.org/10.1016/s2352-3018(20)30099-0
Autor:
Oksana Ocheretina, Lishuang Shen, Vincent E Escuyer, Marie-Marcelle Mabou, Gertrude Royal-Mardi, Sean E Collins, Jean W Pape, Daniel W Fitzgerald
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129207 (2015)
The World Health Organization recommends diagnosing Multidrug-Resistant Tuberculosis (MDR-TB) in high burden countries by detection of mutations in Rifampin (RIF) Resistance Determining Region of Mycobacterium tuberculosis rpoB gene with rapid molecu
Externí odkaz:
https://doaj.org/article/255b882bdd1948c7a8d41dabd9ad7836
Autor:
Amanda Clarke, Axel Baumgarten, Xuelian Wei, David A. Wohl, Diana M. Brainard, Cynthia Brinson, Melanie A. Thompson, Rima Acosta, Hal Martin, Yazdan Yazdanpanah, Andrea Antinori, Debbie Hagins, Sean E Collins, Moti Ramgopal
Publikováno v:
The Lancet HIV. 6:e355-e363
Summary Background Bictegravir co-formulated with emtricitabine and tenofovir alafenamide as a fixed-dose combination is recommended for treatment of HIV-1-infection and might be better tolerated than other integrase inhibitor-based single-tablet reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d1bd17569d69faba5788057fd58af3
https://doi.org/10.1016/s2352-3018(19)30077-3
https://doi.org/10.1016/s2352-3018(19)30077-3